Bioprocessing - Upstream & Downstream

Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!

Our free eBook showcases content on bioprocess scale up, biosimilars, primary packaging considerations, and more.

Sartorius shares its vision for better, faster, and cheaper bioprocessing.

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.

Determining full versus empty capsids remains a key challenge with adeno-associated viral vectors.

Experts from Sartorius give advice on the next generation processes and facilities for mRNA manufacture.

How can new analytical tech help biopharma manufacturers?

Find out how digital transformation creates a competitive advantage and emphasizes Bachem’s technical leadership.